跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
OMLYCLO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
OMLYCLO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Celltrion Healthcare Hungary Kft.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 6, 2024
Approval ID
172b7f2f832e556e
Company
Celltrion Healthcare Hungary Kft.
Type
Standard
Approval Details
Approval Id
172b7f2f832e556e
Drug Cima Aemps Name
OMLYCLO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1241817002
Holder Company Name
Celltrion Healthcare Hungary Kft.
Marketing Company Name
Celltrion Farmacéutica (España) S.L.
Holder Company Detail Path
/organization/celltrion-healthcare-hungary-kft
Authorization Date
2024-09-06
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
150 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Celltrion Healthcare Hungary Kft.
Company Detail Path
/organization/celltrion-healthcare-hungary-kft
Company Information
Pharmaceutical Company Name
Celltrion Healthcare Hungary Kft
Country Name
Hungary
Active Ingredients
OMALIZUMAB
150 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 6, 2024
Approval ID
172b7f2f832e556e
Type
Standard
Back to CIMA-AEMPS Approvals
OMLYCLO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details